Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2874 of 5804
-
Could a common bladder drug help boys with rare birth defect?
Disease control Recruiting nowBoys with posterior urethral valves have bladder dysfunction of varying severity. Early treatment of these children with anticholinergics is recommended by some teams, although there have never been any clear studies on the subject. To our knowledge, no comparative study of the e…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Virus and radiation combo takes aim at rare sarcomas
Disease control OngoingThe purpose of this research study is to determine the safety and tolerability of talimogene laherparepvec when combined with radiation therapy. Approximately 46 people will take part in this study conducted by investigators at the University of Iowa.
Phase: PHASE1, PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Veterans sharpen thinking skills from home in new TBI study
Symptom relief CompletedThis study will use technology to deliver effective treatment for cognitive problems associated with TBI to Veterans at home, which may result in improved daily functioning and increased access to health care for the growing population of aging Veterans with history of TBI. The s…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Smartphone mood tracking may predict Post-Stroke depression
Knowledge-focused CompletedThe recent development of acute phase treatments has dramatically improved stroke functional outcome but post-stroke neuropsychiatric disorders, notably post-stroke depression, continue to contribute to the heavy burden of stroke. While these conditions affect about 25% of stroke…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Dry needling may unlock stiff muscles after stroke
Symptom relief OngoingThe study team is recruiting 20 adults with spasticity due to chronic stroke and 20 adults with no neurological injuries for a 2 day study. In people with chronic stroke, one of the most common and disabling problems is spasticity (increased muscle tone or muscle stiffness). The …
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New app aims to reboot language after stroke
Symptom relief CompletediTALKBetter will provide an app-based therapy for people with word retrieval difficulties who have had a stroke. This study aims to test the therapy application for people with naming difficulties through a small scale item-randomized controlled trial.
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Promising combo for relapsed leukemia in kids hits early hurdle
Disease control TerminatedThe purpose of the phase 1 portion (dose escalation) of the study was to establish an optimally safe and biologically active recommended phase 2 dose (RP2D) and/or to determine maximum tolerated dose (MTD) for gilteritinib in sequential combination with fludarabine, cytarabine an…
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Spesolimab shows promise for Long-Term control of painful hand and foot pustules
Disease control TerminatedThis study is open to people with palmoplantar pustulosis who took part in previous clinical studies of a medicine called spesolimab. Participants who benefited from spesolimab treatment in the previous studies can join this study. The purpose of this study is to find out how sa…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill aims to slow vision loss in rare usher syndrome
Disease control CompletedThis study will examine the safety and efficacy of NPI-001 Tablets as compared to placebo for 24 months in subjects with vision loss due to RP associated with Usher syndrome.
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Simple blood draws could spot dementia years early
Knowledge-focused OngoingThis is a biomarker study designed to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) mutations compared to a control group of individuals without known f-FTLD mutations. The NSP is an ancillary study to the …
Sponsor: The Bluefield Project to Cure Frontotemporal Dementia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New model predicts prostate cancer treatment response using PET scans
Knowledge-focused CompletedThis multicenter retrospective study developed and validated a prediction model based on PSMA PET/CT and routine clinical information to estimate early treatment response in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving first-line standard therapy. …
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
MRI scans could revolutionize how we measure muscular dystrophy
Knowledge-focused Recruiting nowThe purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease progression and to serve as an objective outcome measure for clinical trials in Muscular Dystrophy (MD). The investigators will…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New online sleep program shows promise for kids with autism
Symptom relief CompletedThis proposal will acquire preliminary data on the feasibility and effectiveness of an innovative and scalable strategy for improving access to effective sleep health care for preschool-aged children with Autism Spectrum Disorder (ASD). The investigators will develop and test an …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can parent training tame ADHD in preschoolers? new study investigates
Symptom relief Recruiting nowParent education is an effective and relatively cost efficient approach for reducing child behavior problems. Research, however, suggests that the effectiveness of parent education is mitigated by parent attendance and parent implementation of intervention strategies. That is, lo…
Phase: NA • Sponsor: Lehigh University • Aim: Symptom relief
Last updated Jun 26, 2026 14:40 UTC
-
Exercise as medicine? new study tests aerobic training for severe asthma
Symptom relief Recruiting nowThe effects of regular exercise on asthma control has not yet been well demonstrated. The aim of this study is to investigate the impact of submaximal aerobic training on exercise tolerance (VO2max - primary outcome) and a set of secondary outcomes: quality of life, asthma sympt…
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Brain zap test may tailor ADHD meds for kids
Knowledge-focused Recruiting nowAttention-Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in childhood. Children with ADHD struggle in school due to problems with attention and high levels of impulsivity and hyperactivity. They are at substantially increased risk fo…
Phase: PHASE4 • Sponsor: Donald Gilbert, MD, MS, FAAN, FAAP • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Blood test may spare unneeded liver biopsies for fatty liver patients
Diagnosis CompletedBackground: During the hepatology evaluation, vibration-controlled transient elastography (VCTE) is often used as a clinical decision aid to target high-risk patients for liver biopsy. The enhanced liver fibrosis (ELF) test is expected to be approved in the US. We tested the hypo…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Experimental cancer drug tested in patients with no other options
Disease control TerminatedThis phase 1/2 study will evaluate the safety, tolerance and dose of BM7PE treating patients with colorectal cancer who have progressed to standard cell therapy or cannot tolerate such therapy. The study starts as a phase 1 study with the aim of assessing the final recommended do…
Phase: PHASE1, PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a Vaccine-Like shot tame type 1 diabetes?
Disease control CompletedThe study is a randomized, double-masked, placebo-controlled, Phase 1 dose-escalation clinical trial. The objective of the trial is to determine if IBC adjuvanted with MAS-1 is safe and will favor tolerogenic pathways to restore immunologic balance and reverse type 1 diabetes (T1…
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Aging immune systems under the microscope: new study tracks COVID antibodies in nursing homes
Knowledge-focused OngoingThis study aims to determine how long COVID-19 neutralizing antibodies can be detected in an elderly institutionalized population presenting fragility factors. This study also aims to stratify seroconversion by immunological profiles of the elderly patients residing in the EHPAD…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC